Vasculature disruption enhances bacterial targeting of autochthonous tumors

Jeremy J. Drees, Michael J. Mertensotto, Lance B Augustin, Janet L Schottel, Daniel A Saltzman

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Attenuated Salmonella enterica serovar Typhimurium (S. Typhimurium) has been developed as a vector to deliver therapeutic agents to tumors. The potential of S. Typhimurium in cancer therapy is largely due to its reported propensity to accumulate at greater than 1,000-fold higher concentrations in tumors relative to healthy tissues. In this study, we compared bacterial colonization of tumors in a subcutaneous transplantation model with a more clinically relevant autochthonous tumor model. Following intravenous administration of attenuated S. Typhimurium strain SL3261, we observed approximately 10,000-fold less bacteria in autochthonous tumors that sporadically develop in transgenic BALB-neuT mice compared to tumors developed from subcutaneous transplantation of 4T1 murine breast cancer cells in BALB/c mice. Treatment of BALB-neuT mice with a vasculature-disrupting agent (VDA) prior to bacterial treatment caused necrosis of tumor tissue and significantly increased the bacterial targeting of autochthonous tumors by approximately 1,000-fold. These observations emphasize the importance of appropriate model selection in developing bacteria-based cancer therapies and demonstrate the potential of combining VDA pre-treatment with bacteria to facilitate targeting of clinically relevant tumors.

Original languageEnglish (US)
Pages (from-to)843-848
Number of pages6
JournalJournal of Cancer
Volume6
Issue number9
DOIs
StatePublished - Jan 1 2015

Fingerprint

Neoplasms
Bacteria
Therapeutics
Transplantation
Salmonella enterica
Intravenous Administration
Necrosis
Breast Neoplasms
Serogroup

Keywords

  • 4T1
  • Autochthonous
  • BALB-neuT
  • Breast cancer
  • Cancer therapy
  • Combretastatin A-4
  • Necrosis
  • Salmonella
  • Spontaneous
  • Tumor-targeting
  • Vasculature disruption

Cite this

Vasculature disruption enhances bacterial targeting of autochthonous tumors. / Drees, Jeremy J.; Mertensotto, Michael J.; Augustin, Lance B; Schottel, Janet L; Saltzman, Daniel A.

In: Journal of Cancer, Vol. 6, No. 9, 01.01.2015, p. 843-848.

Research output: Contribution to journalArticle

@article{a47dd0929ff743b9b3bf3470f208d497,
title = "Vasculature disruption enhances bacterial targeting of autochthonous tumors",
abstract = "Attenuated Salmonella enterica serovar Typhimurium (S. Typhimurium) has been developed as a vector to deliver therapeutic agents to tumors. The potential of S. Typhimurium in cancer therapy is largely due to its reported propensity to accumulate at greater than 1,000-fold higher concentrations in tumors relative to healthy tissues. In this study, we compared bacterial colonization of tumors in a subcutaneous transplantation model with a more clinically relevant autochthonous tumor model. Following intravenous administration of attenuated S. Typhimurium strain SL3261, we observed approximately 10,000-fold less bacteria in autochthonous tumors that sporadically develop in transgenic BALB-neuT mice compared to tumors developed from subcutaneous transplantation of 4T1 murine breast cancer cells in BALB/c mice. Treatment of BALB-neuT mice with a vasculature-disrupting agent (VDA) prior to bacterial treatment caused necrosis of tumor tissue and significantly increased the bacterial targeting of autochthonous tumors by approximately 1,000-fold. These observations emphasize the importance of appropriate model selection in developing bacteria-based cancer therapies and demonstrate the potential of combining VDA pre-treatment with bacteria to facilitate targeting of clinically relevant tumors.",
keywords = "4T1, Autochthonous, BALB-neuT, Breast cancer, Cancer therapy, Combretastatin A-4, Necrosis, Salmonella, Spontaneous, Tumor-targeting, Vasculature disruption",
author = "Drees, {Jeremy J.} and Mertensotto, {Michael J.} and Augustin, {Lance B} and Schottel, {Janet L} and Saltzman, {Daniel A}",
year = "2015",
month = "1",
day = "1",
doi = "10.7150/jca.12491",
language = "English (US)",
volume = "6",
pages = "843--848",
journal = "Journal of Cancer",
issn = "1837-9664",
publisher = "Ivyspring International Publisher",
number = "9",

}

TY - JOUR

T1 - Vasculature disruption enhances bacterial targeting of autochthonous tumors

AU - Drees, Jeremy J.

AU - Mertensotto, Michael J.

AU - Augustin, Lance B

AU - Schottel, Janet L

AU - Saltzman, Daniel A

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Attenuated Salmonella enterica serovar Typhimurium (S. Typhimurium) has been developed as a vector to deliver therapeutic agents to tumors. The potential of S. Typhimurium in cancer therapy is largely due to its reported propensity to accumulate at greater than 1,000-fold higher concentrations in tumors relative to healthy tissues. In this study, we compared bacterial colonization of tumors in a subcutaneous transplantation model with a more clinically relevant autochthonous tumor model. Following intravenous administration of attenuated S. Typhimurium strain SL3261, we observed approximately 10,000-fold less bacteria in autochthonous tumors that sporadically develop in transgenic BALB-neuT mice compared to tumors developed from subcutaneous transplantation of 4T1 murine breast cancer cells in BALB/c mice. Treatment of BALB-neuT mice with a vasculature-disrupting agent (VDA) prior to bacterial treatment caused necrosis of tumor tissue and significantly increased the bacterial targeting of autochthonous tumors by approximately 1,000-fold. These observations emphasize the importance of appropriate model selection in developing bacteria-based cancer therapies and demonstrate the potential of combining VDA pre-treatment with bacteria to facilitate targeting of clinically relevant tumors.

AB - Attenuated Salmonella enterica serovar Typhimurium (S. Typhimurium) has been developed as a vector to deliver therapeutic agents to tumors. The potential of S. Typhimurium in cancer therapy is largely due to its reported propensity to accumulate at greater than 1,000-fold higher concentrations in tumors relative to healthy tissues. In this study, we compared bacterial colonization of tumors in a subcutaneous transplantation model with a more clinically relevant autochthonous tumor model. Following intravenous administration of attenuated S. Typhimurium strain SL3261, we observed approximately 10,000-fold less bacteria in autochthonous tumors that sporadically develop in transgenic BALB-neuT mice compared to tumors developed from subcutaneous transplantation of 4T1 murine breast cancer cells in BALB/c mice. Treatment of BALB-neuT mice with a vasculature-disrupting agent (VDA) prior to bacterial treatment caused necrosis of tumor tissue and significantly increased the bacterial targeting of autochthonous tumors by approximately 1,000-fold. These observations emphasize the importance of appropriate model selection in developing bacteria-based cancer therapies and demonstrate the potential of combining VDA pre-treatment with bacteria to facilitate targeting of clinically relevant tumors.

KW - 4T1

KW - Autochthonous

KW - BALB-neuT

KW - Breast cancer

KW - Cancer therapy

KW - Combretastatin A-4

KW - Necrosis

KW - Salmonella

KW - Spontaneous

KW - Tumor-targeting

KW - Vasculature disruption

UR - http://www.scopus.com/inward/record.url?scp=84947802972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947802972&partnerID=8YFLogxK

U2 - 10.7150/jca.12491

DO - 10.7150/jca.12491

M3 - Article

VL - 6

SP - 843

EP - 848

JO - Journal of Cancer

JF - Journal of Cancer

SN - 1837-9664

IS - 9

ER -